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Posterior lamellar versus bilamellar tarsal rotation surgery 
for trachomatous trichiasis in Ethiopia: a randomised 
controlled trial
Esmael Habtamu, Tariku Wondie, Sintayehu Aweke, Zerihun Tadesse, Mulat Zerihun, Zebideru Zewudie, Amir Bedri Kello, Chrissy H Roberts, 
Paul M Emerson, Robin L Bailey, David C W Mabey, Saul N Rajak, Kelly Callahan, Helen A Weiss, Matthew J Burton
Summary
Background Eyelid surgery is done to correct trachomatous trichiasis to prevent blindness. However, recurrent 
trichiasis is frequent. Two procedures are recommended by WHO and are in routine practice: bilamellar tarsal 
rotation (BLTR) and posterior lamellar tarsal rotation (PLTR). This study was done to identify which procedure gives 
the better results.
Methods A randomised, controlled, single masked clinical trial was done in Ethiopia. Participants had upper lid 
trachomatous trichiasis with one or more eyelashes touching the eye or evidence of epilation, in association with 
tarsal conjunctival scarring. Exclusion criteria were age less than 18 years, recurrent trichiasis after previous surgery, 
hypertension, and pregnancy. Participants were randomly assigned (1:1) to either BLTR or PLTR surgery, stratiﬁ ed by 
surgeon. The sequences were computer-generated by an independent statistician. Surgery was done in a community 
setting following WHO guidelines. Participants were examined at 6 months and 12 months by assessors masked to 
allocation. The primary outcome was the cumulative proportion of individuals who developed recurrent trichiasis by 
12 months. Primary analyses were by modiﬁ ed intention to treat. The intervention eﬀ ect was estimated by logistic 
regression, controlled for surgeon as a ﬁ xed eﬀ ect in the model. The trial is registered with the Pan African Clinical 
Trials Registry (number PACTR201401000743135).
Findings 1000 participants with trichiasis were recruited, randomly assigned, and treated (501 in the BLTR group and 
499 in the PLTR group) between Feb 13, 2014, and May 31, 2014. Eight participants were not seen at either 6 month or 
12 month follow-up visits and were excluded from the analysis: three from the PLTR group and ﬁ ve from the BLTR 
group. The follow-up rate at 12 months was 98%. Cumulative recurrent trichiasis by 12 months was more frequent in 
the BLTR group than in the PLTR group (110/496 [22%] vs 63/496 [13%]; adjusted odds ratio [OR] 1·96 [95% CI 
1·40–2·75]; p=0·0001), with a risk diﬀ erence of 9·50% (95% CI 4·79–14·16).
Interpretation PLTR surgery was superior to BLTR surgery for management of trachomatous trichiasis, and could be 
the preferred procedure for the programmatic management of trachomatous trichiasis.
Funding The Wellcome Trust.
Copyright © Habtamu et al. Open Access article distributed under the terms of CC BY.
Introduction
Trachoma, a neglected tropical disease caused by 
Chlamydia trachomatis, is the leading infectious cause of 
blindness.1 Recurrent infection drives progressive 
conjunctival scarring, which turns the lid and eyelashes 
in towards the eye (trichiasis) resulting in pain and 
eventually blinding corneal opaciﬁ cation. About 
1·2 million people are irreversibly blind from this disease 
and about 7·2 million have trichiasis.1,2  WHO 
recommends the SAFE strategy for trachoma control: 
Surgery for trichiasis, Antibiotics, Facial cleanliness, and 
Environmental improvement.3 Trichiasis surgery reduces 
the risk of sight loss by correcting the in-turned eyelid, 
thus stopping the corneal damage. Surgery involves an 
incision through the scarred upper eyelid, parallel to the 
lid margin, outward rotation, and suturing in the 
corrected position.4 Due to the limited number of 
ophthalmologists in most trachoma-endemic countries, 
surgery is usually done by non-physicians with limited 
training, equipment, and time.3 Given these constraints, 
the technique needs to be simple, safe, and quick to do, 
whereas at the same time giving consistently good results.
Unfortunately, trichiasis frequently recurs after surgery. 
This outcome represents a substantial limitation in 
preventing sight loss from trachoma. Studies have 
reported trichiasis recurrence rates between 10% at 
3 months and up to 60% at 3 years, with an average of 
around 20% at 1 year.5–14 Several factors contribute to 
recurrent trichiasis, including preoperative disease 
severity, surgeon skill, and surgical procedure.15 Among 
these, operation type is a major determinant of outcome 
and subtle variations in procedure performance probably 
aﬀ ect results.10,11,16 Many diﬀ erent surgical procedures have 
been used to correct trichiasis, with some evidence that 
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bilamellar tarsal rotation (BLTR) is better than others to 
which it has been formally compared.10,11,15,17 However, it is 
important to determine which is the best of these options.
About 20 years ago several procedures were compared 
with the BLTR operation in randomised controlled 
trials.10,11 The ﬁ ndings from these trials showed that the 
BLTR procedure had the lowest trichiasis recurrence rate 
of the procedures compared (about 20% at 1 year), 
leading WHO to recommend it as the preferred 
operation.3 However, the most commonly used alternative 
procedure, the posterior lamellar tarsal rotation (PLTR) 
or Trabut operation, was not included in these earlier 
trials. One earlier randomised trial from Ethiopia 
compared variants of the BLTR and PLTR, and found 
no diﬀ erence. However, that trial was relatively small, 
with only 3 months’ follow-up and was done by 
ophthalmologists in a teaching hospital, precluding 
conclusions for control programmes that do the vast 
majority of trichiasis surgery.13
There is an unprecedented eﬀ ort to scale up global 
trichiasis surgery output and improve outcomes, to 
clear the huge trichiasis backlog. This eﬀ ort requires 
training many trichiasis surgeons on the easiest, safest, 
and most successful operation with the least recurrence 
and complications. There is an urgent need to examine 
rigorously which of these two most frequently 
performed operations has the best outcomes in a 
programmatic setting, with an adequate sample size 
and follow-up period. This question was identiﬁ ed as a 
research priority several years ago by the WHO Alliance 
for the Global Elimination of Trachoma by 2020 
(GET2020).18 The aim of our trial was to determine 
whether BLTR or PLTR surgery gives superior results 
under programmatic conditions.
Methods
Study design and participants
This was a single-masked, individual-randomised, 
controlled trial done in Ethiopia. Adults with trachomatous 
trichiasis were randomly allocated to either BLTR or PLTR 
surgery, stratiﬁ ed by surgeon, and followed up for 1 year. 
The study was approved by the Ethiopian National Health 
Research Ethics Review Committee, the London School of 
Hygiene & Tropical Medicine Ethics Committee, Emory 
University Institutional Review Board, and the Ethiopia 
Food, Medicine and Healthcare Administration and 
Controls Authority. The trial was done in compliance with 
the Declaration of Helsinki and International Conference 
on Harmonisation–Good Clinical Practice. An independent 
data and safety monitoring committee oversaw the trial.
Participants had upper lid trachomatous trichiasis with 
one or more eyelashes touching the eye or evidence of 
epilation, in association with tarsal conjunctival scarring. 
We excluded people with trichiasis due to other causes, 
recurrent trichiasis after previous surgery, hypertension, 
pregnancy, and those under 18 years. Patients were 
recruited mainly through community-based screening in 
three districts of West Gojam Zone, Amhara Region, 
Ethiopia. Recruitment and surgery were performed in 
community level health centres. Written informed 
consent in Amharic was obtained before enrolment from 
participants. If a participant was unable to read and 
write, the information sheet and consent form were read 
to them and their consent recorded by thumbprint.
Randomisation and masking
Participants were randomly assigned (1:1) to either PLTR 
or BLTR surgery for each surgeon, with random block 
sizes of 4 or 6. Randomisation was stratiﬁ ed by surgeon 
Research in context
Evidence before this study
Members of our study group recently published a systematic 
review of the management of trachomatous trichiasis (Burton 
and colleagues, 2015). When preparing this systematic review, 
we searched CENTRAL, Ovid MEDLINE, Embase, ISRCTN registry, 
ClinicalTrials.gov, and WHO ICTRP. We searched until May 7, 
2015, using the search terms “trachoma” and “trichiasis”. See 
the review’s appendix for full search methods for each database. 
We identiﬁ ed one previous randomised trial (Adamu and 
Alemayehu, 2002), which compared variants of the BLTR and 
PLTR procedure done by ophthalmologists in a teaching hospital 
environment in Ethiopia; 153 patients were randomly assigned 
and followed for 3 months. No evidence of a diﬀ erence in 
outcome was found. However, this earlier study was constrained 
by a small sample size and short duration. The surgery was 
performed in a teaching hospital setting by ophthalmologists, 
in contrast to the health centre provision by non-physicians 
typical of trachoma control programmes, limiting the 
conclusions that can been drawn. 
Added value of this study
Our trial was designed to compare the two most common 
operations used to treat trachomatous trichiasis to determine 
which gives the best results in terms of disease recurrence and 
complications in a programmatic setting. The results show 
that the PLTR was superior to BLTR because it had a 
substantially lower trichiasis recurrence rate by 1 year and 
fewer intraoperative and immediate postoperative 
complications.
Implications of all the available evidence
This study provides evidence of superiority of PLTR, 
suggesting that it could be the best procedure for the 
programmatic management of trachomatous trichiasis. We 
suggest that new surgical trainees in both established and 
new programmes be trained in the PLTR procedure. Another 
trial examining the outcomes of PLTR surgery done by 
surgeons previously trained in BLTR surgery should be 
considered. 
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because of potential intersurgeon variability. The 
sequences were computer-generated by an independent 
statistician. Separate allocation sequences for each 
surgeon were concealed in sequentially numbered, 
sealed, opaque envelopes. A person independent of all 
other aspects of the trial prepared these envelopes.
On most recruitment days, two surgeons operated 
simultaneously. Following baseline examination, 
participants were allocated to the next available surgeon. 
A ﬁ eldworker was responsible for implementing the 
intervention assignment in a dedicated area. The 
ﬁ eldworker and surgeon jointly conﬁ rmed the allocation 
and recorded this in the surgical logbook. The diﬀ erent 
surgical equipment sets for the two procedures were kept 
separately. The randomisation ﬁ eldworker and surgeon 
jointly collected the appropriate surgical set for the 
allocated procedure. Surgeons and patients were aware 
of the allocation. The two examiners (EH, SA) who were 
responsible for clinical observations at baseline, 
6 months, and 12 months were masked to the allocation. 
They were not involved in the allocation process, surgery, 
postoperative care, or the 10 day follow-up. The 
intraoperative and 10 day observations were made by 
separate ﬁ eldworkers who could not be masked to 
the allocation.
Procedures
At the preoperative assessment before randomisation, 
demographic characteristics were recorded. Presenting 
logMAR (logarithm of the minimum angle of resolution) 
visual acuity at 2 m was measured using PeekAcuity 
software on a smartphone in a dark room.19 For visual 
acuities of counting ﬁ ngers or less, logMAR values were 
attributed as follows: counting ﬁ ngers, 2·0; hand 
movements, 2·5; perception of light, 3·0; and no 
perception of light, 3·5.8 We assessed contrast sensitivity 
with a prototype smartphone-based test that presents 
calibrated grey scale spots against a white background, 
which are identiﬁ ed by touch.
Eyes were examined by a single examiner (EH) using 
2·5× binocular loupes and torch, and graded using the 
Detailed WHO FPC Grading System.20 Lashes touching 
the eye were counted and subdivided by the part of the 
eye contacted: cornea, lateral, or medial conjunctiva. 
Trichiasis subtypes were recorded: metaplastic, 
misdirected, and entropic.21 Clinical evidence of epilation 
was identiﬁ ed by broken or newly growing lashes, or 
areas of absent lashes. Upper lid entropion was graded by 
assessing the degree of eyelid margin inward rotation.21 
Corneal scarring was graded using a previously described 
detailed system.20 Three standardised high-resolution 
digital photographs of trichiasis, cornea, and tarsal 
conjunctiva were taken, using a Nikon D90 digital SLR 
camera with 105 mm macro lens and R1C1 ﬂ ash units.22
Before recruitment, nine experienced trichiasis nurse-
surgeons, already trained, certiﬁ ed, and regularly 
performing PLTR surgery were trained in BLTR surgery. 
We followed the procedures described in the WHO 
Trichiasis Surgery for Trachoma manual.4 After training, 
surgeons were carefully observed throughout ﬁ ve 
operations and certiﬁ ed as correctly doing the procedure 
following the standardisation checklist.4 Surgeons then 
returned to their usual workplace, and regularly 
performed BLTR for 6 months. They then returned for 
repeat standardisation, assessment, and certiﬁ cation on 
both PLTR and BLTR procedures by two assessors. Before 
Figure: Trial proﬁ le
501 assigned to bilamellar 
tarsal rotation surgery
500 patients seen
1 not found or travelled1 not found or travelled
11 not seen
1 died
1 travelled
4 moved away
3 declined
2 no information
490 patients seen493 patients seen
490 patients seen491 patients seen
11 not seen
5 died
5 moved away
1 declined
5 not analysed
1 died
3 moved away
1 declined
3 not analysed
1 died
2 declined
496 included in the analysis496 included in the analysis
10 day follow-up
6 month follow-up
12 month follow-up
1000 patients enrolled and randomly assigned
5168 patients assessed for eligibility
4168 excluded
3854 had other ocular conditions
312 had trichiasis but did not 
meet inclusion criteria
2 declined
499 assigned to posterior 
lamellar tarsal rotation 
surgery
498 patients seen
6 not seen
1 died
2 travelled
1 moved away
2 declined
8 not seen
4 died
1 travelled
1 moved away
2 declined
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commencing the trial, each surgeon had done about 
100 BLTR procedures (median 117, range 94–137). The 
best six surgeons did the surgery in this trial: they were 
all certiﬁ ed as consistently performing all component 
steps of both operations correctly, using the WHO 
certiﬁ cation procedures.
The procedures are described in detail in the WHO 
manual.4 Brieﬂ y, in the PLTR the eyelid is everted, an 
incision is made through the tarsal conjunctiva and tarsal 
plate (posterior lamella), parallel to and 3 mm above the 
lid margin. The posterior lamella is separated from the 
anterior lamella (orbicularis muscle and skin). Three 
sutures are placed to externally rotate and ﬁ x the eyelid. 
In the BLTR the eyelid is ﬁ xed with a clamp (Waddell 
type), of an appropriate size.23 A full-thickness incision is 
made through the anterior and posterior lamellae, 
parallel to and 3 mm above the lid margin. Three sutures 
are placed to externally rotate and ﬁ x the eyelid. Surgery 
was done under subcutaneous local anaesthesia (2–3 mL 
of lidocaine 2%, with adrenaline). In both surgical 
procedures, 4/0 silk sutures with 3/8th circle, 19 mm 
cutting needles were used. Surgery duration was 
measured and complications documented. Post-
operatively, operated eyes were padded for 1 day and 
tetracycline eye ointment 1% was self-administered twice 
daily for 2 weeks. Participants were not given perio-
perative oral azithromycin because it is not the 
operational practice to use it in this region.
Participants were examined at 10 days, 6 months, and 
12 months after operation. At 10 days, data were collected 
on patient-reported outcomes (improvement in 
preoperative symptoms, postoperative pain, and 
functioning). Participants were examined for recurrence, 
degree of lid eversion, infection, granulomata, and eyelid 
contour abnormality (ECA) before suture removal.
At 6 months and 12 months participants were re-
examined following the same procedures as for baseline 
(SA at 6 months and EH at 12 months). The examiners 
were standardised and had very strong agreement for 
the primary outcome in grading validation studies 
(κ=0·95). Based on severity, trichiasis cases were 
categorised into minor trichiasis with less than six lashes 
or evidence of epilation in less than one third of the lid 
margin, and major trichiasis with six or more lashes or 
evidence of epilation in one third or more of the lid 
margin. The degree of entropion correction was graded 
as follows: (grade 1) extra eversion: main lashes point 
superiorly, whole lid margin visible, and tarsal plate 
surface visible; (grade 2) lid margin eversion: lashes 
point superiorly, whole lid margin visible, and tarsal 
surface not visible; (grade 3) partial lid margin entropion: 
some parts of the lashes might point anteriorly and 
some part of the lid margin not visible; (grade 4) total lid 
margin entropion: lashes might point inferiorly or 
towards the globe and lid margin is not visible. We 
considered grade 1 over-correction, grade 2 normal 
correction, and grades 3 and 4 under-correction. 
Granulomata were deﬁ ned as ﬂ eshy tissue growth of at 
least 2 mm on the tarsal conjunctiva or at the edge of the 
eyelid.12 Grading of ECAs was based on the PRET trial 
method: mild, vertical deviation from the natural 
contour less than 1 mm in height and aﬀ ecting more 
than one third of horizontal eyelid length; moderate, 
vertical deviation from the natural contour 1–2 mm in 
height or aﬀ ecting one third to two thirds of horizontal 
eyelid length; severe, vertical deviation from the natural 
contour more than 2 mm in height or a defect more than 
two thirds the horizontal eyelid length.24 These were 
regrouped as: clinically non-signiﬁ cant ECA, which 
included mild ECA; and clinically signiﬁ cant ECA, 
which included moderate-to-severe ECA. The clinically 
signiﬁ cant ECAs also included other ECAs such as divot, 
which is a scarred depression or tissue loss including 
lashes at the eyelid margin. Visual acuity and contrast 
sensitivity were measured at 12 months. Data on patient-
reported outcomes were collected at 12 months. 
Individuals with recurrent trichiasis during follow-up 
were oﬀ ered repeat surgery. Participants with other 
ophthalmic pathology (eg, cataract) were referred.
High-resolution digital photographs of upper eyelid, 
cornea, and tarsal conjunctiva were taken at 6 months 
and 12 months.22 To address potential concerns of bias 
Baseline 12 months
PLTR group 
(n=499)
BLTR group 
(n=501)
PLTR group 
(n=491)
BLTR group 
(n=490)
Sex (female) 388 (78%) 377 (75%) ·· ··
Age, years (mean, SD) 47·2 (15·0) 47·5 (14·9) ·· ··
Illiterate 441 (88%) 445 (89%) ·· ··
Best corrected logMAR visual acuity in study eye
–0·1 to 0·3 141 (28%) 137 (27%) 175 (36%) 169 (34%)
0·3 to 0·7 190 (38%) 209 (42%) 186 (38%) 212 (43%)
0·7 to 1·1 107 (21%) 103 (21%) 90 (18%) 78 (16%)
1·1 to 2·0 18 (4%) 18 (4%) 10 (2%) 10 (2%)
CF/HM/PL 37 (7%) 27 (5%) 25 (5%) 15 (3%)
NPL 6 (1%) 7 (1%) 4 (1%) 5 (1%)
Not possible to measure ·· ·· 1 (<1%) 1 (<1%)
Entropion grade
0 11 (2%) 7 (1%) 467 (95%) 446 (91%)
1 93 (19%) 85 (17%) 17 (3%) 39 (8%)
2 315 (63%) 334 (67%) 6 (1%) 5 (1%)
3 71 (14%) 66 (13%) 1 (<1%) 0
4 9 (2%) 9 (2%) 0 0
Trichiasis (number of lashes)
No trichiasis ·· ·· 445 (91%) 405 (83%)
None (epilating) 38 (8%) 44 (9%) 7 (1%) 13 (3%)
1–5 316 (63%) 312 (62%) 37 (8%) 66 (13%)
6–9 87 (17%) 87 (17%) 1 (<1%) 5 (1%)
10–19 41 (8%) 46 (9%) 1 (<1%) 1 (<1%)
20+ 17 (3%) 12 (2%) 0 0
Mean (SD)* 5·6 (6·6) 5·4 (5·7) 2·7 (2·7) 2·6 (2·5)
(Table 1 continues on next page)
Articles
www.thelancet.com/lancetgh   Vol 4   March 2016 e179
which might arise from identifying procedure type from 
surgical scars, the upper eyelid photograph was taken 
after covering the incision area with a shaped occluder to 
prevent any unmasking of the independent photograph 
grader (an ophthalmologist with 15 years’ experience of 
examining for trachomatous trichiasis). Images were 
viewed on a 15 inch high-resolution “retina” screen 
(Apple). Trachomatous trichiasis was considered to be 
present if there was one or more lashes touching the eye, 
identiﬁ ed by the lashes deviating over the globe and 
appearing to touch the eye.
Outcomes
The primary outcome was the cumulative proportion of 
individuals who developed recurrent trichiasis by 
12 months. Recurrent trichiasis was deﬁ ned as one or 
more lashes touching the eye or clinical evidence of 
epilation, or a history of repeat trichiasis surgery by 
12 months. A-priori deﬁ ned secondary outcome 
measures were: recurrent trichiasis at 6 months and 
12 months; trichiasis recurrence diﬀ erence by surgeon; 
trichiasis recurrence diﬀ erence by baseline disease 
severity; number, type, and location of recurrent lashes at 
12 months; corneal opacity, vision, and contrast sensitivity 
changes at 12 months; intraoperative, immediate, and 
late postoperative surgical complications (bleeding, 
infection, and granulomas); ECA at 12 months; and 
patient-reported outcomes.
Statistical analysis
In the STAR trial, the 1 year trichiasis recurrence rate 
using BLTR surgery was about 10% (tetracycline group).5 
In our recent trials in Ethiopia involving patients with a 
similar severity of disease to the STAR trial, we found 
PLTR surgery had a 1 year recurrence rate of 18%.8 A 
sample of 836 participants was estimated to have 90% 
power and 95% conﬁ dence to detect a similar diﬀ erence 
in recurrent trichiasis (18% vs 10%). Therefore, we aimed 
to recruit 1000 cases (500 in each group), to allow for 
about 15% loss to follow-up.
Data were double-entered into Access 13 (Microsoft) 
and transferred to Stata 11 (StataCorp) for analysis. For 
participants who had bilateral surgery, we randomly 
designated one eye to be the study eye for the analysis. A 
modiﬁ ed intention-to-treat analysis was done, with 
primary outcome data analysed on all participants seen 
at either the 6 month or 12 month follow-up or both. 
Those not seen at either of these follow-up visits were 
excluded from the analysis.
The primary outcome and binary secondary outcomes 
were compared between the two surgical groups with 
logistic regression analyses to estimate the odds ratio 
(OR) and 95% CI. All comparisons between the 
two surgical procedures were controlled for surgeon as a 
ﬁ xed eﬀ ect in the model to account for the stratiﬁ ed 
randomisation. The risk diﬀ erence in the primary 
outcome (recurrent trichiasis by 12 months) between 
BLTR and PLTR procedures was estimated. The 
possibility of eﬀ ect modiﬁ cation between group and 
a-priori deﬁ ned factors such as surgeon, preoperative 
trichiasis severity, papillary inﬂ ammation, age, and sex 
was investigated by including interaction terms in the 
model and using a likelihood ratio test to assess statistical 
signiﬁ cance of the interaction term. Ordered categorical 
secondary outcomes (changes in visual acuity and 
corneal opacity, bleeding, and patient-reported outcomes) 
were compared between the two surgical interventions 
using ordinal logistic regression. Categorical secondary 
outcomes (type and location of recurrent lashes, ECAs, 
and entropion correction) were analysed using 
multinomial logistic regression to estimate relative risk 
ratio (RRR) and 95% CI. Negative binomial regression 
Baseline 12 months
PLTR group 
(n=499)
BLTR group 
(n=501)
PLTR group 
(n=491)
BLTR group 
(n=490)
(Continued from previous page)
Lash location
None (epilating) 38 (8%) 45 (9%) 7 (15%) 13 (15%)
Corneal with or without 
peripheral
450 (90%) 451 (90%) 30 (65%) 59 (69%)
Peripheral only 11 (2%) 5 (1%) 9 (20%) 13 (15%)
Corneal opacity
None (CC0) 121 (24%) 132 (26%) 155 (32%) 159 (32·5)
Peripheral (CC1) 204 (41%) 201 (40%) 140 (29%) 157 (32·0)
Oﬀ  centre faint (CC2a) 94 (19%) 94 (19%) 98 (20%) 85 (17%)
Oﬀ  centre dense (CC2b) 19 (4%) 11 (2%) 7 (1%) 4 (1%)
Central faint (CC2c) 48 (10%) 50 (10%) 77 (16%) 76 (16%)
Central dense (CC2d) 7 (1%) 7 (1%) 10 (2%) 5 (1%)
Total central dense (CC3) 4 (1%) 6 (1%) 2 (<1%) 4 (1%)
Phthisis (CC4) 2 (<1%) 0 2 (<1%) 0
Tarsal conjunctiva inﬂ ammation
None (P0) 6 (1%) 9 (2%) 9 (2%) 12 (2%)
Mild (P1) 117 (23%) 131 (26%) 104 (21%) 98 (20%)
Moderate (P2) 306 (61%) 297 (59%) 332 (68%) 321 (66%)
Severe (P3) 70 (14%) 64 (13%) 46 (9%) 59 (12%)
Tarsal conjunctival scarring
None (C0) 0 0 ·· ··
Mild (C1) 51 (10%) 56 (11%) ·· ··
Moderate (C2) 373 (75%) 367 (73%) ·· ··
Severe (C3) 75 (15%) 78 (16%) ·· ··
Recurrent trichiasis by surgeon†
1 ·· ·· 8/89 (9%) 27/91 (30%)
2 ·· ·· 14/95 (15%) 17/93 (18%)
3 ·· ·· 12/84 (14%) 17/85 (20%)
4 ·· ·· 10/92 (11%) 17/91 (19%)
5 ·· ·· 6/47 (13%) 12/47 (26%)
6 ·· ·· 13/89 (15%) 20/89 (22%)
Data are n (%) unless otherwise stated. BLTR=bilamellar tarsal rotation. PLTR=posterior lamellar tarsal rotation. 
CF=counting ﬁ ngers. HM=hand movement. PL=perception of light. NPL=no perception of light. *Excluding those 
with no lashes touching the eyeball. †Data are n/N (%). 
Table 1: Baseline and 12 month characteristics of participants
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was used to analyse the diﬀ erence in the number of 
recurrent lashes touching the eye between the two 
intervention groups. The signed-rank test was used to 
analyse visual acuity and contrast sensitivity changes 
between baseline and the 12 month follow-up. The risk of 
trichiasis recurrence diﬀ erence by surgeon between the 
two surgical interventions was analysed using logistic 
regression adjusted for baseline disease severity such as 
entropion and trichiasis. To investigate the possibility of 
a learning curve eﬀ ect during recruitment, the trichiasis 
recurrence rates for the ﬁ rst 50% of cases to be recruited 
versus the second 50% of cases recruited for each 
surgeon were compared using logistic regression 
adjusted for baseline disease severity such as entropion 
and trichiasis. The trial is registered at the Pan African 
Clinical Trials Registry (PACTR201401000743135).
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had ﬁ nal responsibility for 
the decision to submit for publication.
Results
Between Feb 13, 2014, and May 31, 2014, 5168 people 
were examined for eligibility, of whom 1314 (25%) had 
trachomatous trichiasis (ﬁ gure). The remaining 3854 had 
other ocular conditions. Of the 1314 trichiasis cases, 
312 did not meet inclusion criteria, largely because they 
had previously received surgery for trichiasis. Of the 
1002 eligible participants, two (<1%) declined surgery. 
Thus, 1000 trichiasis cases consented, were enrolled, and 
randomly assigned (501 in the BLTR group and 499 in the 
PLTR group).
Participants were reassessed at 10 days (range 7–14) for 
suture removal, 6 months, and 12 months after enrolment. 
Almost all (98%) participants were examined at each 
follow-up. At 10 days, two people had travelled to another 
region, and had sutures removed in their new locality. 
Eight (1%) participants were not seen at either 6 month or 
12 month follow-up visits and were therefore excluded 
from the analysis: three from the PLTR group and ﬁ ve 
from the BLTR group. Hence, primary outcome data were 
available and analysed for 992 (99%): 496 in each group.
Baseline demographic and clinical characteristics were 
balanced between the trial groups (table 1). The majority 
of the participants were female (77%) and their mean age 
was 47·3 years. The two groups were comparable for 
visual acuity and prevalence of corneal opacity, 
conjunctival inﬂ ammation, scarring, entropion, and 
trichiasis. There was evidence of epilation in 588 (59%) 
participants: 281 (56%) in the PLTR group and 307 (61%) 
in the BLTR group; among these 82 (8%) in both groups 
had successfully epilated, with no lashes touching. Major 
trichiasis was present in 145 (29%) of the PLTR group 
and 144 (29%) of the BLTR group. About 90% of the 
participants in both groups had corneal lashes (table 1). 
PLTR surgery took slightly less time than BLTR surgery 
(15 min 33 s vs 16 min 39 s; p<0·0001).
By 12 months, the primary outcome, cumulative 
recurrent trichiasis, had developed in 173 (17%) of 
992 study eyes. Cumulative recurrence was signiﬁ cantly 
more frequent in the BLTR group (110/496 [22%]) than in 
the PLTR group (63/496 [13%]); after adjusting for 
surgeon, the OR was 1·96 (95% CI 1·40–2·75; p=0·0001). 
The risk diﬀ erence for recurrent trichiasis between BLTR 
PLTR group BLTR group OR or RRR (95% CI) p value
Cumulative recurrence by baseline trichiasis severity*
Minor trachomatous 
trichiasis
26/266 (10%) 36/257 (14%) 1·47 (0·85–2·53) 0·16
Major trachomatous 
trichiasis
37/230 (16%) 74/239 (31%) 2·29 (1·46–3·59) 0·0003
Cumulative recurrence by baseline entropion severity*
None or mild 11/102 (11%) 28/90 (31%) 3·98 (1·80–8·80) 0·0007
Moderate 37/314 (12%) 59/331 (18%) 1·59 (1·02–2·49) 0·04
Severe 15/80 (19%) 23/75 (31%) 2·04 (0·95–4·37) 0·07
Number of recurrent lashes 
(mean, SD)†
2·67 (2·72) 2·65 (2·45) 0·97‡ (0·71–1·32) 0·84
Types of recurrent lashes§
Entropic 4/46 (9%) 10/85 (12%) 1·79¶ (0·48–6·69) 0·38
Metaplastic (base outcome) 32/46 (70%) 55/85 (65%) 1 ··
Misdirected 3/46 (6%) 7/85 (8%) 1·37¶ (0·32–5·99) 0·67
Epilating 7/46 (15%) 13/85 (15%) 1·26¶ (0·43–3·69) 0·68
Location of recurrent lashes§
Corneal or corneal and 
peripheral (base outcome)
30/46 (65%) 59/85 (69%) 1 ··
Peripheral 9/46 (20%) 13/85 (15%) 0·82¶ (0·30–2·22) 0·69
Epilating 7/46 (15%) 13/85 (15%) 1·08¶ (0·37–3·12) 0·89
Visual acuity change||
Worse 123/490 (25%) 111/489 (23%) 0·97 (0·77–1·23) 0·81
Same 172/490 (35%) 198/489 (41%)
Better 195/490 (40%) 180/489 (37%)
Contrast sensitivity||
Worse 114/490 (23%) 100/489 (20%) 1·05 (0·83–1·32) 0·71
Same 149/490 (30%) 165/489 (34%)
Better 227/490 (46%) 224/489 (46%)
Corneal opacity change||
More opacity 84/491 (17%) 68/490 (14%) 1·19 (0·92–1·55) 0·19
No change 329/491 (67%) 338/490 (69%)
Less opacity 78/491 (16%) 84/490 (17%)
Entropion grade change||
<2 grade change or no 
change
119/491 (24%) 113/490 (23%) 1·07 (0·79–1·44) 0·67
≥2 grade change 372/491 (76%) 377/490 (77%)
Data are n/N (%), unless otherwise stated. BLTR=bilamellar tarsal rotation. PLTR=posterior lamellar tarsal rotation. 
OR=odds ratio. RRR=relative risk ratio. *Analysis done using logistic regression adjusted for surgeon to see the eﬀ ect of 
the two surgical procedures on cumulative recurrence (by 12 months) across baseline trichiasis and entropion severity 
level. †Analysis done using negative binomial regression. ‡Incidence rate ratio. §Multinomial logistic regression. 
¶Relative risk ratio. ||Ordinal logistic regression. 
Table 2: Secondary clinical outcomes and changes in clinical phenotype at 12 months
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and PLTR procedures was 9·50% (95% CI 4·79–14·16). 
There was no evidence of eﬀ ect modiﬁ cation between 
group and a-priori deﬁ ned other factors on the primary 
outcome, including surgeon.
The primary outcome analysis using the photograph 
grading results was similar to the ﬁ eld grading. By 
12 months, cumulative recurrent trichiasis was recorded 
for 250 (25%) of 992 study eyes. Recurrence was 
signiﬁ cantly more frequent in the BLTR group than in 
the PLTR group (32% vs 19%; OR 1·97 [95% CI 
1·47–2·65]; p<0·0001). The risk diﬀ erence for recurrent 
trichiasis between BLTR and PLTR procedures was 
12·5% (95% CI 7·2–17·8).
At 10 days, recurrent trichiasis was present in three 
study eyes, one in the PLTR group and two in the BLTR 
group. At 6 months, recurrent trichiasis was present in 
114 (12%) of 983 study eyes, and was signiﬁ cantly more 
frequent in the BLTR group than the PLTR group (71 [14%] 
vs 43 [9%]; OR 1·77 [95% CI 1·19–2·65]; p=0·0001). At 
12 months, recurrent trichiasis was present in 131 (13%) of 
981 study eyes and again remained signiﬁ cantly more 
frequent in the BLTR group than the PLTR group (85 [17%] 
vs 46 [9%]; OR 2·04 [95% CI 1·39–2·99]; p=0·0003).
There was no evidence of a diﬀ erence in the risk of 
trichiasis recurrence between surgeons by 12 months for 
either PLTR (p=0·80) or BLTR (p=0·44), or for a learning 
curve during the course of the trial for either procedure. 
For PLTR, recurrence risks during the ﬁ rst and second 
half of recruitment were 32 (13%) of 248 and 31 (12%) of 
248, respectively (p=0·68). For BLTR, recurrence risks 
during the ﬁ rst and second half of recruitment were 
55 (22%) of 247 and 55 (22%) of 249, respectively (p=0·93).
The number, type, and location of recurrent lashes 
were comparable between the two groups (tables 1 
and 2). BLTR surgery had more frequent recurrence 
than PLTR surgery for major trichiasis cases and across 
all baseline entropion grades. There was no evidence of 
a diﬀ erence in visual acuity, contrast sensitivity, corneal 
opacity, and entropion changes at 12 months between 
the two groups (table 2). However, compared with the 
baseline, at 12 months there was a statistically signiﬁ cant 
overall improvement in visual acuity (baseline median 
logMAR, 0·6 [IQR 0·3–0·8] vs 12 month median 
logMAR, 0·5 [0·2–0·7]; signed-rank test, p<0·0001) and 
contrast sensitivity (baseline median contrast sensitivity, 
3% [2–5] vs 12 month contrast sensitivity, 2% [1–3]; 
signed-rank test, p<0·0001) in the entire combined 
study sample.
After adjusting for surgeon, there was evidence of a 
diﬀ erence in odds of intraoperative, immediate, or late 
postoperative complications between the two surgical 
interventions (table 3). There was more intraoperative 
and immediate postoperative bleeding in the BLTR 
surgery group than the PLTR surgery group (OR 2·76 
PLTR group BLTR group OR or RRR (95% CI) p value
Intraoperative or postoperative bleeding*
Mild 490/499 (98%) 477/501 (95%) 2·76 (1·27–6·00) 0·01
Moderate 8/499 (2%) 18/501 (4%)
Excessive 1/499 (<1%) 6/501 (1%)
Sign of infection at 7–14 days†‡ 9/498 (2%) 37/500 (7%) 4·44 (2·11–9·33) 0·0001
Granuloma by 12 months† 26/496 (5%) 11/496 (2%) 0·41 (0·20–0·83) 0·01
Lagophthalmos (present) 3/491 (1%) 7/490 (1%)
Eyelid contour abnormality at 12 months§
None (base outcome) 371/491 (76%) 404/490 (82%) 1 ··
Clinically non-signiﬁ cant (mild) 89/491 (18%) 49/490 (10%) 0·50¶ (0·34–0·73) 0·000
Clinically signiﬁ cant (moderate-to- severe) 31/491 (6%) 37/490 (8%) 1·10¶ (0·66–1·81) 0·72
Central correction at 12 months§
Corrected (base outcome) 468/491 (95%) 454/490 (93%) 1 ··
Over-corrected 12/491 (2%) 6/490 (1%) 0·52¶ (0·19–1·39) 0·19
Under-corrected 11/491 (2%) 30/490 (6%) 2·81¶ (1·39–5·68) 0·004
Medial correction at 12 months§
Corrected (base outcome) 469/491 (96%) 450/490 (92%) 1 ··
Over-corrected 0 0 ··
Under-corrected 22/491 (4%) 40/490 (8%) 1·90¶ (1·11–3·26) 0·02
Lateral correction at 12 months§
Corrected (base outcome) 486/491 (99%) 469/490 (96%) 1 ··
Over-corrected 1/491 (<1%) 0 ·· ··
Under-corrected 4/491 (1%) 21/490 (4%) 5·44¶ (1·85–16·00) 0·002
Data are n/N (%), unless stated otherwise. BLTR=bilamellar tarsal rotation. PLTR=posterior lamellar tarsal rotation. OR=odds ratio. RRR=relative risk ratio. *Ordinal logistic 
regression. †Logistic regression. ‡Erythematous swelling and discharge. §Multinomial logistic regression. ¶Relative risk ratio.  
Table 3: Complications and eyelid contour abnormalities
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[95% CI 1·27–6·00]; p=0·01), and also more postoperative 
infection in the BLTR surgery group than the PLTR 
surgery group (OR 4·44 [95% CI 2·11–9·33]; p=0·0001; 
table 3). Granulomata were less frequent in the BLTR 
group compared with the PLTR group (OR 0·41 [95% CI 
0·20–0·83]; p=0·01; table 3).
The frequency of clinically non-signiﬁ cant (mild) ECA 
at 12 months was lower in the BLTR surgery group than 
the PLTR surgery group (RRR 0·50 [95% CI 0·34–0·73]; 
p<0·0001; table 3). However, there was no evidence of a 
diﬀ erence in the frequency of clinically signiﬁ cant 
(moderate-to-severe) ECA between the two groups 
(RRR 1·10 [95% CI 0·66–1·81]; p=0·72; table 3). A similar 
pattern in ECA was found by independent photograph 
grading. Clinically mild ECA at 12 months was less 
frequent in the BLTR group (27/484 [5%]) than in the 
PLTR group (58/489 [12%]; RRR 0·43 [95% CI 0·27–0·70]; 
p=0·001). However, again we found no evidence of a 
diﬀ erence in moderate-to-severe ECA between the 
two groups (BLTR, 4% vs PLTR, 5%; RRR 0·76 [95% CI 
0·41–1·44]; p=0·40). There was evidence of more under-
correction at 12 months with BLTR surgery than PLTR 
surgery (table 3).
There was no evidence of a diﬀ erence between groups 
in the patient-reported pain experienced during surgery 
(p=0·84; table 4). However, participants in the BLTR 
group reported more pain and discomfort during the 
days between surgery and suture removal than the PLTR 
group (OR 1·46 [95% CI 1·12–1·89]; p=0·004; table 4). 
There was no evidence of a diﬀ erence in patient 
satisfaction between the two groups for treatment of 
trichiasis (p=0·20) or the cosmetic appearance of the 
operated eyelid (p=0·64; table 4).
Discussion
Around 7 million people have trachomatous trichiasis 
and require high-quality surgical intervention.2 A major 
global eﬀ ort exists to scale up surgical programmes. 
However, high postoperative trichiasis recurrence rates 
are undermining trachoma control.25 Identifying the 
surgical intervention with the lowest recurrence rate has 
been a research priority for many years.18 In this trial, we 
compared the relative eﬀ ectiveness of the two most 
commonly used operations and found that PLTR surgery 
has a signiﬁ cantly lower trichiasis recurrence rate at 
12 months than BLTR surgery, particularly for more 
severe cases.
Considerable care was taken to ensure that the surgeons 
did both procedures using the WHO-described method 
with equal precision.4 We trained surgeons who had been 
previously taught PLTR to do the BLTR procedure. This 
approach was chosen, rather than training novice 
surgeons simultaneously in both procedures, to reduce 
the learning curve to achieve proﬁ ciency in the new 
procedure.26 During training and standardisation, before 
the commencement of the trial, each surgeon did about 
100 BLTR operations and was conﬁ rmed by two assessors 
to be performing the procedure per protocol, using the 
WHO Certiﬁ cation process.4
There is clear evidence that during the trial the 
surgeons continued to do both operations consistently 
well and that the recorded diﬀ erence in the primary 
outcome was not attributable to having learnt the BLTR 
procedure more recently. First, there were only three 
recurrent cases by 10 days, indicating that primary 
surgical failure was rare. If the recorded diﬀ erences in 
recurrence were due to poor surgical technique, we 
would anticipate this to be more apparent by 10 days. 
This ﬁ nding suggests that the subsequent diﬀ erence in 
the primary outcome is attributable to fundamental 
diﬀ erences in the surgical method that achieves a more 
stable and long-lasting correction in the case of PLTR 
surgery. Second, trichiasis recurrence rates between the 
ﬁ rst and second half of recruitment were very similar. 
If surgeons were still on a BLTR learning curve, a lower 
recurrence rate in the second half of recruitment would 
have been anticipated. Third, there was no signiﬁ cant 
diﬀ erence in recurrence for either surgical procedure 
between surgeons. Finally, the recurrence rates for both 
procedures were generally similar to or lower than 
those reported in other trials, with the exception of the 
STAR trial which reported a lower BLTR recurrence 
rate.5–14
The only other trial to compare BLTR and PLTR 
procedures was done in Ethiopia.13 This trial reported 
comparable outcomes for the two procedures: BLTR, 
PLTR group BLTR group OR* (95% CI) p value
Pain during surgery
None 441/499 (88%) 441/501 (88%) 1·04 (0·71–1·53) 0·84
Mild 40/499 (8%) 39/501 (8%)
Moderate 7/499 (1%) 11/501 (2%)
Severe 11/499 (2%) 10/501 (2%)
Pain between surgery and suture 
removal
None 347/498 (70%) 309/500 (62%) 1·46 (1·12–1·89) 0·004
Mild 94/498 (19%) 107/500 (21%)
Moderate 38/498 (8%) 56/500 (11%)
Severe 19/498 (4%) 28/500 (6%)
Satisfaction with the eﬀ ect of 
surgery on the trichiasis at 
12 months
Satisﬁ ed 463/491 (94%) 452/490 (92%) 1·39 (0·84–2·31) 0·20
Neither satisﬁ ed nor dissatisﬁ ed 13/491 (3%) 16/490 (3%)
Dissatisﬁ ed 15/491 (3%) 22/490 (4%)
Satisfaction with the cosmetic 
appearance at 12 months
Satisﬁ ed 465/491 (95%) 461/490 (94%) 1·14 (0·66–1·97) 0·64
Neither satisﬁ ed nor dissatisﬁ ed 10/491 (2%) 7/490 (1%)
Dissatisﬁ ed 16/491 (3%) 22/490 (4%)
Data are n/N (%), unless stated otherwise. BLTR=bilamellar tarsal rotation. PLTR=posterior lamellar tarsal rotation. 
OR=odds ratio. *Ordinal logistic regression.
 Table 4: Patient-reported outcomes
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10·4%, and PLTR, 12·3%, recurrence at 3 months. 
However, this earlier study had a number of constraints. 
First, it was under-powered to detect a diﬀ erence 
(153 patients, 256 eyes operated). Second, it was done at a 
tertiary teaching hospital by ophthalmologists. By 
contrast, most programmatic trichiasis surgery is done 
by non-physicians with limited training in remote, low-
level, health facilities. Alternative techniques might give 
diﬀ erent results in more programmatic settings. Third, 
the 3 month follow-up period was too short to assess the 
relative performance because diﬀ erences might take 
longer to become apparent.6,7,11,27,28
The PLTR surgical procedure did better than BLTR 
for several secondary outcomes. A higher rate of 
postoperative infection occurred following BLTR, 
probably because of the skin incision. All infections 
were treated successfully with oral antibiotics. The 
skin and orbicularis incision probably also explains the 
greater intraoperative and postoperative bleeding and 
postoperative pain that occurred with the BLTR 
procedure because these structures have an extensive 
vascular and sensory supply. These are important 
considerations for improving surgical uptake, which 
might be reduced by patient reports of pain and 
bleeding. Participants reported very high levels of 
satisfaction with the cosmetic outcome and eﬀ ect of 
surgery in alleviating the trichiasis in both groups at 
12 months. There was no diﬀ erence by group. However, 
some caution needs to be taken in drawing ﬁ rm 
conclusions from such data; the questions were asked 
by members of the study team, and there could be 
some reticence in expressing dissatisfaction in this 
context. Of note, the Kenyan National Trachoma 
Control Programme recently switched from the BLTR 
to PLTR surgery because of reports of widespread 
patient dissatisfaction with the appearance of the full-
thickness incision in BLTR surgery. Under-correction 
was more frequent with BLTR surgery at 12 months, 
suggesting it is less eﬀ ective at correcting underlying 
entropion.
We found that BLTR had a lower rate of mild ECAs. We 
consider this degree of ECA to be clinically and 
cosmetically non-signiﬁ cant because the vertical 
deviation from the lid contour is less than 1 mm. It is 
possible that this diﬀ erence reﬂ ects consistently greater 
degrees of evertion with PLTR. There was no diﬀ erence 
in moderate-to-severe ECA by group. Conjunctival 
granulomata developed more frequently after PLTR 
surgery.8 Granulomata are probably a vigorous healing 
response that occurs in a tissue defect.12 The additional 
rotation eﬀ ected by the PLTR might create a larger 
posterior lamella defect and thereby a higher likelihood 
of granuloma formation. However, they are usually a 
minor complication that either self-resolve or need only a 
simple shave under topical anaesthesia. In the earlier 
comparison of BLTR and PLTR in Ethiopia, both eyelid 
notching and granulomata were signiﬁ cantly more 
common in the BLTR group than in the PLTR group 
(p=0·002).13
We think that it is biologically plausible that the PLTR 
achieves a more eﬀ ective and stable correction of the 
entropion and trichiasis due to a key diﬀ erence in 
technique from the BLTR. In the PLTR procedure, the 
lower edge of the dissected upper portion of the tarsal 
plate is drawn down and tucked into the dissected space 
between the anterior lamella and the lower portion of the 
tarsal plate behind.4 Once healed, this provides a wedge 
of tissue that continues to rotate the distal end of the 
eyelid outwards, and stabilise the correction.
This study has several strengths. It had a large sample 
size and very high follow-up rates. Demographic and 
clinical characteristics were balanced between groups. 
The surgeons were rigorously trained and standardised 
to ensure the procedures were done correctly.
A potential design limitation in a trial of these 
two procedures is the risk of unmasking at the time of 
follow-up observations because some BLTR cases might 
very occasionally have a faint skin scar. The baseline, 
6 month, and 12 month observers were masked to the 
randomisation. However, to independently assess the 
primary outcome for observer bias, photographs in 
which the upper lid skin was covered by a mask were 
graded. We found that the analysis of primary outcome 
using ﬁ eld and photograph grading were comparable, 
showing no systematic bias in the ﬁ eld grading. The 
observations of some of the secondary outcomes made 
during the operative procedure and at 10 days were 
impossible to mask. The use of surgeons who had 
previously been trained in PLTR and then provided with 
a second round of training in BLTR could be viewed as a 
potential limitation. However, we think that there was 
ample pre-trial training, practice, and assessment to 
bring the surgeons to a proﬁ cient standard, and that 
there is clear evidence that during the trial high standards 
were maintained, as discussed above. In this trial we 
used silk sutures, which were removed at 10 days. 
Although absorbable sutures such as polyglactan-910 
(vicryl) oﬀ er the operational advantage of not needing to 
be removed, we have previously found in a randomised 
trial that silk and absorbable sutures have comparable 
outcomes, and therefore it is unlikely that the outcome of 
this present study would be modiﬁ ed by their use.8
Overall, the PLTR procedure was superior to the BLTR 
in terms of lower trichiasis recurrence and fewer 
intraoperative and immediate postoperative com-
plications. All other factors being equal, PLTR could be 
the preferred procedure for the programmatic 
management of trachomatous trichiasis. We suggest 
new surgical trainees in both established and new 
programmes should be trained in the PLTR procedure. 
Additionally, consideration could be given to further 
research to investigate whether individuals previously 
trained to do BLTR surgery need to be re-trained in 
PLTR surgery.
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